CN Patent

CN117924280B — 取代噻吩基-5-氟-1h-吡唑并吡啶类化合物及其用途

Assigned to Academy of Military Medical Sciences AMMS of PLA · Expires 2024-07-12 · 2y expired

What this patent protects

本发明涉及新型取代噻吩基‑5‑氟‑ 1H ‑吡唑并吡啶类化合物及其用途。具体地说，本发明涉及式（I）所示化合物，所述化合物的制备方法、含有所述化合物的药物组合物和联合产品，以及所述化合物、药物组合物或联合产品在制备用于治疗和/或预防心衰等疾病的药物中的用途，。

USPTO Abstract

本发明涉及新型取代噻吩基‑5‑氟‑ 1H ‑吡唑并吡啶类化合物及其用途。具体地说，本发明涉及式（I）所示化合物，所述化合物的制备方法、含有所述化合物的药物组合物和联合产品，以及所述化合物、药物组合物或联合产品在制备用于治疗和/或预防心衰等疾病的药物中的用途，。

Drugs covered by this patent

Verquvo (VERICIGUAT) · Merck & Co.

Patent Metadata

Patent number: CN117924280B
Jurisdiction: CN
Classification: —
Expires: 2024-07-12
Drug substance claim: No
Drug product claim: No
Assignee: Academy of Military Medical Sciences AMMS of PLA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.